HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxyhemoglobins (Oxyhemoglobin)

A compound formed by the combination of hemoglobin and oxygen. It is a complex in which the oxygen is bound directly to the iron without causing a change from the ferrous to the ferric state.
Also Known As:
Oxyhemoglobin; Oxycobalt Hemoglobin; Oxycobalthemoglobin; Hemoglobin, Oxycobalt
Networked: 1044 relevant articles (33 outcomes, 93 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Gottlieb, Daniel J: 11 articles (01/2021 - 10/2006)
2. Redline, Susan: 10 articles (01/2021 - 05/2002)
3. Schwartz, Alan R: 9 articles (03/2021 - 07/2007)
4. Gozal, David: 8 articles (10/2021 - 03/2006)
5. Vasan, Ramachandran S: 6 articles (01/2021 - 10/2006)
6. Polotsky, Vsevolod Y: 6 articles (01/2019 - 11/2008)
7. Tromberg, Bruce J: 6 articles (01/2013 - 06/2003)
8. Zinchuk, V V: 5 articles (06/2022 - 02/2002)
9. Li, Zengyong: 5 articles (01/2022 - 10/2014)
10. Patel, Sanjay R: 5 articles (01/2022 - 01/2019)

Related Diseases

1. Apnea
2. Hypoxia (Hypoxemia)
3. Central Sleep Apnea (Central Sleep Apnea Syndrome)
12/15/1999 - "Treatment with O2 resulted in a significant reduction in AHI (49+/-19 vs 29+/-29, means+/-SD), central apnea index (28+/-23 vs 13+/-18 per hour), and the percent of total sleep time below an arterial oxyhemoglobin saturation of 90% (23+/-21% vs 0.8+/-2.3%). "
01/01/2022 - "The lowest arterial oxyhemoglobin saturation (min SaO₂) (P = 0.007) was lower, the percentage of time spent below arterial oxyhemoglobin saturation less than 90% (T90) (P = 0.005) was higher, and central apnea index per hour (CAI/h) (P = 0.04) was higher among the deceased. "
07/01/2003 - "SHHS methodologies have been previously reported and include performance of overnight, in-home polysomnography (PSG), which recorded variables reflecting sleep architecture and breathing, permitting identification of obstructive and central apneas, hypopneas, periodic breathing and oxyhemoglobin saturation (SpO(2)). "
05/01/2002 - "Relative to the first-night PSG, on the second PSG, we observed the following: shorter latency to rapid eye movement (REM) sleep (P<0.001), increased sleep efficiency (P<0.01), decreased wake after sleep onset (WASO) time (P<0.01), decreased percentage of non-REM time with oxyhemoglobin saturation by pulse oximetry (SpO(2))< or =90% (P<0.05), decreased number of central apneas per hour (P<0.05) and reduced respiratory rate in stage 2 sleep on night 2 (P<0.05). "
07/01/2022 - "In 67% of these cases, MMA resulted in CMAI% <25 (median CMAI%, 6.1%; 2.1-8.9) and significantly improved the apnea-hypopnea index (AHI) (p < 0.001), the lowest oxyhemoglobin saturation (p < 0.001), central and mixed apnea index (p < 0.001), percentage of central and mixed apneas of total AHI (p = 0.004), central apnea index (p < 0.001), and mixed apnea index (p < 0.001). "
4. Obstructive Sleep Apnea
5. Chronic Obstructive Pulmonary Disease (COPD)

Related Drugs and Biologics

1. Oxygen (Dioxygen)
2. Hemoglobins (Hemoglobin)
3. Nitric Oxide (Nitrogen Monoxide)
4. deoxyhemoglobin
5. Lactic Acid (Lactate)
6. Carbon Dioxide
7. Hypnotics and Sedatives (Sedatives)
8. esmolol (Brevibloc)
9. Electron Transport Complex IV (Cytochrome c Oxidase)
10. Acetazolamide (Diamox)

Related Therapies and Procedures

1. Therapeutics
2. Noninvasive Ventilation
3. Warm Ischemia
4. Aftercare (After-Treatment)
5. Lasers (Laser)